Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian CarcinomaKsenija Nesic, Clare L. Scott, Rachel M. Hurley et al.|Cancer Research|2021Cited by 91
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune systemNirashaa Bound, Clare L. Scott|Frontiers in Genetics|2022Cited by 23